SNN Valorisation grant for Sulfateq B.V.

We are proud to announce that Sulfateq B.V. received a Samenwerkingsverband Noord-Nederland (SNN) Valorisation grant for the development of SUL-138 as Acute Kidney Injury (AKI) prophylaxis. This grant helps us to continue the development that was already stimulated by...

New Paper about SUL-109

There is a new manuscript available which describes the positive effect of our SUL-109 compound which is commercially available as our ROKEPIE preservation solution. This article was written by Fatima Aerts from the Hacettepe University in Ankara (Turkey). You can...

Winterslaap voor de mens

In de zomer keihard doorgaan, en zodra het koud wordt, even de boel de boel laten. Rust. Voor velen aanlokkelijk, maar het lijkt nog toekomstmuziek. Professor Rob Henning (Rijksuniversiteit Groningen) scientific board van Sulfateq, denkt dat het in de toekomst...

HypoThermosol and ROKEPIE compared

We are happy to share a new article about our product ROKEPIE which can be used to preserve cells and tissues during transport and storage. A direct comparison of HypoThermosol¬ģ and ROKEPIE was recently published in PlosONE. Freitas Robero from the group of Prof. Rui...

BIO-Europe 2018 – November 5-7

BIO-Europe is coming up in less than 2 weeks. Will you be there? If so, make sure that you schedule a meeting with our director Kees van der Graaf. We would be delighted to meet to explore ways that our SUL-compounds could help preventing acute kidney injury. Please...